AGA Family of Websites:


3 Awards

1 Year Term


3 Awards

1 Year Term

This award provides $30,000 for one year to independent investigators at any career stage researching new directions to improve the diagnosis and treatment of non-alcoholic steatohepatitis (NASH). Funding for this award is provided by Pfizer, Inc.


Applications Under Review


Applications Under Review


The objective of this AGA Research Foundation Pilot Research Award is to provide funds for early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators. Projects must focus on the pathophysiology, epidemiology, prevention, diagnosis, treatment or patient outcomes of non-alcoholic steatohepatitis (NASH).

Applicant eligibility

Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty position or equivalent at an institution in North America (U.S., Canada or Mexico).

AGA membership is required at the time of application submission. Please visit the AGA membership page or call 301-654-2055 for membership information.

Applicants performing any type of research (basic, translational, clinical) relevant to digestive disorders are eligible to apply.

Applicants who are physician-scientists, female or from racial/ethnic groups underrepresented in biomedical research are strongly encouraged to apply.

Application requirements

  • The proposed research must focus on the pathophysiology, epidemiology, prevention, diagnosis, treatment or patient outcomes of NASH.
  • Early career investigators are required to have a mentor for this award. The mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables.
    • MD applicants are considered “early career” if no more than seven years have elapsed following the completion of clinical training (GI fellowship or its equivalent) at the start date (i.e., April 2024) of this award.
    • PhD applicants are considered “early career” if no more than seven years have elapsed following the awarding of the PhD degree and the start date (i.e., April 2024) of this award.
  • For all applicants at the instructor or assistant professor level, a letter of recommendation from their division chief or department chair that outlines support of the applicant and their research project is required.
  • Established investigators who are applying for this award should state explicitly how the proposed research is different from their previous line(s) of investigation.
  • The application must indicate how the principal investigator will use the pilot data as an extension of their work that will allow them to apply for additional funding through another agency, such as NIH.
  • A completed research facilities and resources form must be submitted.
  • Biographical sketches for the applicant, mentor (if applicable) and all key personnel must be submitted.
  • A list of the applicant’s current and pending other support.
  • Upon notification of receipt of this award, the recipient must provide approval from the appropriate institutional committee(s) for use of human subjects or animals. If approval is not necessary, the recipient must provide documentation from the appropriate regulatory committee.
  • Recipients must submit scientific and financial progress reports to AGA upon completion of the award and as needed at the request of the AGA Research Foundation.
  • Additional pre-award policies are available for reference.

Budgeting requirements

  • Applicants must use AGA’s budget template, as provided in the application form.
  • The following expenses are allowable:
    • Salary and benefits of the principal investigator.
    • Salary and benefits of research assistants, laboratory technicians and/or other key personnel.
    • Biostatistics support.
    • Supplies, animals, equipment or other materials necessary for the proposed research.
  • The following expenses are not allowed:
    • Salary and benefits of the mentor.
    • Indirect costs.
    • Travel costs.

Award overlap

At the time of application submission, applicants may not hold awards directly related to the proposed research from another organization (e.g., government agency, foundation, academic institution, professional society). If the applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

Selection criteria

The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, evidence of institutional commitment, relevance to AGA’s mission and the overall likelihood that the project will lead to subsequent, more substantial grants.

Review process

A selection committee comprising members of the AGA Research Awards Panel will review the proposals and select the award recipients. Funding will commence in April 2024.

Application process

The application deadline is Sept. 13, 2023. Applications are only accepted through the AGA Grants Management System. Click the “Apply Now” button to create an account and/or submit an application. Applicants may preview the application as it will appear in the AGA Grants Management System. Please note that this template is for reference only; all applications are completed online by selecting the “Apply Now” button.


Please direct all questions to the AGA Awards Program at [email protected].


Funding for this award is provided by Pfizer, Inc.